NeuroBo Pharmaceuticals, Inc. Common Stock

Go to NeuroBo Pharmaceuticals, Inc. Common Stock Website

$2.36

(%)
Live
Previous Close

$2.36

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

The 73rd Emerging Growth Conference is scheduled for July 17-18, 2024, featuring presentations from various companies in the healthcare, technology, and energy sectors.

Related tickers: IMRN, GDTC, GRST, NRBO, NBIO, BIXT, ATRA, RGBP, AAWH, CVKD, AYTU, CLNN, CLNNW, IQST, ASPI, CYIO, XXII, LGMK.

Read Full Article

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The S&P 500 also rose, gaining, 0.87% to 4,887.70. Check This Out: $320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying   Leading and Lagging Sectors   Consumer staples shares rose by 1.6% on Thursday. In trading on Thursday, energy shares fell by 0.2%.   Top Headline   Honeywell International Inc (NASDAQ: HON) reported downbeat revenue for its fourth quarter and issued weak outlook. Honeywell reported fourth-quarter fiscal 2023 sales of $9.44 billion, up 3% year-over-year on a reported basis and +2% on an organic basis, missing the consensus of $9.70 billion. Adjusted EPS was $2.60 (+3% Y/Y), beating the consensus of $2.59. For the first quarter, Honeywell sees adjusted EPS of $2.12-$2.22 (consensus $2.24) and sales of $8.9 billion-$9.2 billion (consensus $9.248 billion).   Equities Trading UP   Cimpress plc (NASDAQ: CMPR) shares shot up 23% to $92.54 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares. Shares of NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) got a boost, surging 72% to $5.61 after the company announced FDA clearance of the IND for a Phase 1 clinical trial of DA-1726 ...

Related tickers: HON, NRBO, CMPR, REVB, PTON, CELU, VLCN.

Read Full Article
Trending Tickers

Please sign in to view